JPRN-UMIN000002220
Completed
未知
se of accelerator Mass Spectrometry to measure the pharmacokinetics and metablites analysis of C14-labled tolbutamide - Use of accelerator Mass Spectrometry to measure the pharmacokinetics and metablites analysis of C14-labled tolbutamide
Conditionshealthy volunteer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- healthy volunteer
- Sponsor
- APDD
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •the investigators must ensure that all subjects being considered meet the following exclusion criteria or conditions 1\)diabetes or blood glucose abnormality 2\)dysemia 3\)history of cardiac disease 4\)impairmant of liver or kidney functions 5\)any medical condition that reqires medical attention 6\)recent (past 4 months) participation in other clinical trial and the investigator determines this trial participation inadequate 7\)history of allergy to tolbutamide 8\)donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation, or donation of component blood within 2 weeks prior to participation 9\)positive serologic reaction of syphilis, positive results of HIV test, HBsAg and HCVAb 10\)history of multiple and recurning allergies to medicines or food 11\)history of drug or alcohol abuse 12\)the investigator determines this trial participation inadequate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Establishment of mass spectrometric determination of drugs in hair and its application to forensic medicine and pharmacokinetic analysisDrug abuseJPRN-UMIN000013312Osaka Medical College5
Recruiting
Not Applicable
Multidimensional mass-spectrometry for early detection of severe sepsis/septic shock in patients with neutropenic fever – a pilot study.A41.9Sepsis, unspecifiedDRKS00000647Institut für Klinische Chemie und LaboratoriumsdiagnostikCenter for Sepsis Control and Care (CSCC)Klinikum Lobeda120
Not yet recruiting
Not Applicable
Validation of 3.0 Tesla 1H-MR Spectroscopy for assessment of liver steatosis in patients with non-alcoholic fatty liver disease and chronically infected hepatitis Cfatty liverhepatitis Cjaundiceliversteatosis10019654NL-OMON31271Academisch Medisch Centrum60
Completed
Not Applicable
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operabilityDrug intoxicationJPRN-UMIN000035447Teikyo University500
Completed
Not Applicable
ovel mass spectrometric monitoring (steroid metabolomics) to detect treatment success and chronic over- or under-treatment in children with CAH (CAH metabolomics).NL-OMON44301Erasmus MC, Universitair Medisch Centrum Rotterdam50